This inventor holds 19 USPTO granted patents and 13 published patent applications and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Salix Pharmaceuticals, Inc., Biotechnology Research Associates, J.v., Scios Nova, Inc.. Active years: 1986-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Castro Valley, CA (US) (1986 - 1988)
- Pleasanton, CA (US) (1988 - 1999)
- Palo Alto, CA (US) (2008 - 2015)
Company Filing History:
8 out of 65 
4 out of 4 
3 out of 40 
Years Active: 1986-2015
Areas of Expertise:
Title: Innovations of Lorin K Johnson: A Pioneer in Pharmaceutical Patents
Introduction
Lorin K Johnson, based in Pleasanton, California, is a notable inventor with an impressive portfolio of 19 patents. His work primarily focuses on enhancing the bioavailability of various pharmaceuticals, particularly in formulations that incorporate specific food administration methods.
Latest Patents
Among his recent advancements are two significant patents related to the formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives. The first patent details a method for increasing the bioavailability of balsalazide when administered with food. This method includes an oral dosage form of balsalazide contained in a suitable package alongside printed labeling that highlights the increased effectiveness of the medication when consumed with food.
The second patent mirrors the first in structure but shifts focus to the 5-aminosalicylate compound, providing a similar method of increasing its bioavailability through oral dosage forms taken with food. This consistency in approach underscores Johnson’s commitment to optimizing pharmaceutical efficacy.
Career Highlights
Lorin K Johnson has contributed significantly to the pharmaceutical sector, with his experience spanning essential roles at reputable companies such as Salix Pharmaceuticals, Inc. and Biotechnology Research Associates, Inc. His innovations have not only advanced product formulations but also improved patient outcomes in medication.
Collaborations
Throughout his career, Johnson has collaborated with noted professionals in his field, including John A Lewicki and John P Longenecker. These partnerships reflect his ability to work within teams, further driving innovation in pharmaceutical research and development.
Conclusion
Lorin K Johnson stands out as a key figure in the realm of pharmaceutical inventions, especially concerning the bioavailability of critical medications. His 19 patents and collaboration with leading professionals mark him as a significant contributor to advancements in drug formulation and delivery methods. As innovations in this sector continue to evolve, Johnson’s work remains influential and invaluable.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile